Hematology Analyzers and Reagents
Medical Device

Hematology Analyzers and Reagents Market 2020: Escalating Adoption of Smart Point-of-Care Devices

 

The hematology analyzers and reagents market is highly competitive in nature with considerable number of players, having a high level of consolidation overall revenue share. Most of the companies operating in the hematology analyzers and reagents market are present globally and have wide distribution and sales network through partnerships or authorized dealers.

Merck KGaA and Thermo Fisher Scientific Inc. Notable Market Participants in Hematology Analyzers and Reagents Industry

The most notable market participants are Clinical Diagnostic Solutions, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Danaher, BIO-RAD LABORATORIES INC., Abbott, Diatron, ERBA Diagnostics Inc., EKF Diagnostics, HORIBA Medical, and Biosystems S.A. occupying a considerable share of the market owing to their offerings to the market.

Market leaders are involved in extensive research for the development of new hematology analyzers and reagents and therapeutics with better efficiency and treatment outcomes. For instance, in May 2018, EKF Diagnostics, the global in-vitro diagnostics company, announced U.S. Food and Drug Administration 510(k) clearance and CLIA waiver for the Company’s hand-held, reagent-free hemoglobin analyzer, the DiaSpect Tm. The device is cleared for use in point of care (POC) and Certificate of Waiver settings, such as physicians’ offices, clinics and other non-traditional laboratory locations.

Many well-known as well as small local companies are present in the market to provide diversified products to its customers. The larger firms are adopting the strategy of acquiring small firms to enhance its product portfolio and expand its footprint in different geographies. Additionally various companies are also undergoing other strategic alliances such as collaborations and others to garner their significance and remain competitive in the market. Few on the important key developments from the industry are mentioned below:

Year

News

Region

2020

Beckman Coulter launched DxH 690T hematology analyzer in the U.S. Designed to streamline workflow and minimize downtime in mid-volume laboratories, the DxH 690T delivers all of the benefits of the company’s flagship DxH 900 large-volume hematology analyzer in a table-top configuration.

North America

2019

ERBA Diagnostics Mannheim GmbH (Mannheim, Germany) launched its latest hematology analyzers at MedLab Middle East, an international platform for laboratory management and medicine that was held between February 4-7, 2019, at the Dubai International Convention and Exhibition Centre, Dubai, UAE

Middle East & Africa

2019

HORIBA Medical and LABORATORIO ECHEVARNE, one of the major Laboratory Medicine providers in Europe have signed a multi-year, multi-site contract for the supply of the high range fully automated Hematology analyzers during the EuroMedLab congress

Europe